Work

Faculty Opinions recommendation of Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.

Year: 2023
Type: peer-review
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4321379164
Cites:
Cited by:
Related to: 10